FDA advisory panels recommend OTC access to morning-after pill

Two FDA advisory panels voted separately to recommend to the agency that it approve over-the-counter dispensing of the Plan B "morning-after" contraceptive. The controversial pill, in the process of being sold by Women's Capital to Barr Laboratories, could be bought over the counter by women who wish to use it within 72 hours of sexual intercourse.

View Full Article in:

Washington Post (tiered subscription model), The · NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA